Follow The Filings

LBRX LB Pharmaceuticals

LB Pharmaceuticals earnings company data as of 4:45 AM ET 11/1

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS -1.52 — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
424B3
8-K 5.02,7.01,9.01
8-K 5.02,7.01,9.01
424B3
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
424B3
SCHEDULE 13G/A —
8-K 1.01,3.02,7.01,9.01
424B3
8-K 8.01,9.01
424B3
SCHEDULE 13G —
8-K 5.02,9.01
424B3
8-K 5.07
424B3
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q

Insider forms

Forms 3, 4 and 5 from EDGAR, 3 rows shown

Filed Form Detail Links
4 Period Oct 9, 2026 (2 forms)
4 Period Jul 30, 2026
4 Period Jun 3, 2026 (2 forms)

5 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.